In recent years, brain changes indicated by MRI, combined with skin biopsy pathological results and genetic testing [fragile X mental retardation 1 (FMR1) or Notch 2 N-terminal-like C (NOTCH2NLC) testing] can contribute to the accurate diagnosis of NIID. The gene discussed is FMR1; the disease is neuronal intranuclear inclusion disease.